Condition

Acute Myocardial Infarction

ClinicalTrials.gov condition label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 71 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials71

Recruiting6

Common interventions25

Lead sponsors shown15

Clinical trials

60 shown

Using an Intervention Adapted to the Health Literacy Level to Improve Adherence to Medical RecommendationsNCT03951467 · 2025-06-26

Clinical Evaluation of NIRSense Tissue Oximetry Sensor Monitoring to Early Detect Cardiogenic ShockNCT07825363 · 2025-06-17

Study of Patients Admitted to a Cardiac Intensive Care Unit With Acute CardioVascular DiseaseNCT06081205 · 2023-04-27

CT Stress Myocardial Perfusion, Fractional Flow Reserve and Angiography in Patients With Stable Chest Pain SyndromesNCT04709900 · 2021-12-03

Assessment of ECMO in Acute Myocardial Infarction Cardiogenic ShockNCT04184635 · 2021-10-14

Peri-treatment of SGLT-2 Inhibitor on Myocardial Infarct Size and Remodeling Index in Patients With Acute Myocardial Infarction and High Risk of Heart Failure Undergoing Percutaneous Coronary InterventionNCT04899479 · 2021-07-05

The Benefits of Wearable AI in Post-Discharge Management of AMI PatientsNCT07288229 · 2025-12-30

NOT_YET_RECRUITING

Noninvasive Assessment of Pulmonary Fluid Levels by Remote Dielectric Sensing Technology to Improve Cardiac InsUfficieney During Ischemia-Reperfusion and Clinical Outcomes in MyocArdiaL InfarctionNCT06671067 · 2024-11-01

NOT_YET_RECRUITING

Effect of Oral Semaglutide on Epicardial and Pericoronary Adipose Tissues in Type 2 Diabetes After Myocardial InfarctionNCT06557811 · 2024-09-01

Influence of Enteral Microbiome on Mortality of Patients With Cardiogenic ShockNCT06006754 · 2023-08-30

Addressing Social Vulnerabilities in Cardiovascular DiseaseNCT03613064 · 2023-06-01

Pulmonary Hypertension on Prognosis of Acute Myocardial Infarction Patients With Reduced Left Ventricular FunctionNCT06186713 · 2023-03-30

Glucose Monitoring After Acute Myocardial Infarct in People With DiabetesNCT05431296 · 2023-02-07

Mulltimodal Dynamic Risk Assessment Systems of Heart Failure in Patients With Myocardial Infarction.NCT05760157 · 2023-01-01

The Use of a Monitoring Device by General Practitioners During Out-of-hours CareNCT05222711 · 2022-05-01

Metformin and Prevention of Cardiovascular Events in Patients With Acute Myocardial Infarction and Prediabetes (MIMET)NCT05182970 · 2021-12-02

The SWISSHEART Failure Network (SHFN)NCT05603247 · 2021-11-01

Twenty-year Follow-up of the Inter99 CohortNCT05166447 · 2021-09-13

ENROLLING_BY_INVITATION

Improving Cardiac Rehabilitation Outcomes Through Mobile Case Management (iCARE)NCT04938661 · 2021-07-08

Dapagliflozin Effects on Mayor Adverse Cardiovascular Events in Patients With Acute Myocardial Infarction (DAPA-AMI)NCT04717986 · 2021-01-26

Dapagliflozin Effects on Cardiometabolic Outcomes in Patients With an Acute Heart Attack.NCT04564742 · 2020-12-22

Switching From Cardiac Troponin I to TNCT05748691 · 2020-10-25

Optimized Cardioprotection Therapy in Obese Subjects With AMINCT04570514 · 2020-10-01

The Development of Quantitative Ultrasound Imaging Software PlatformNCT05836246 · 2020-09-01

Prognostic Value of Lung Ultrasound in ST Segment Elevation Acute Myocardial Infarction (LUS-AMI)NCT04526535 · 2020-06-15

Inflammation-mediated Coronary Plaque Vulnerability, Myocardial Viability and Ventricular RemodelingNCT03830944 · 2019-07-25

Pilot Study of ILIADE : Exploring Health Literacy Within Patients Hospitalized for Acute Cardiovascular EventsNCT03949309 · 2019-06-24

Enhancing Cardiac Rehabilitation Through Behavioral NudgesNCT03834155 · 2019-05-17

Stress Management Modified Cardiac Rehabilitation in Patients After Acute Myocardial Infarction or Heart FailureNCT03905187 · 2019-04-16

Iron in Patients With Cardiovascular DiseaseNCT03991000 · 2019-02-28

Flublok v. Standard Dose Vaccine Effectiveness Among Kaiser Permanente Northern California Adults 18-64 YearsNCT03694392 · 2018-09-16

Psyhosomatic Medicine in Oncologic and Cardiac Disease StudyNCT03437642 · 2018-03-27

Incidence Rate of Heart Failure After Acute Myocardial Infarction With Optimal TreatmentNCT03297164 · 2017-12-21

Impact of EMpagliflozin on Cardiac Function and Biomarkers of Heart Failure in Patients With Acute MYocardial InfarctionNCT03087773 · 2017-05-11

Prospective ARNI vs ACE Inhibitor Trial to DetermIne Superiority in Reducing Heart Failure Events After MINCT02924727 · 2016-12-09

Evaluation of Novel Risk Factors and Clinical Outcomes of Acute Myocardial InfarctionNCT02641184 · 2015-12-01

Copeptin Registry (proCORE) Biomarkers in Cardiology (BIC)-19NCT02490969 · 2015-09-01

Eplerenone in Heart Failure TreatmentNCT02344199 · 2015-03-01

Specialized Community Disease Management to Reduce Substance Use and Hospital ReadmissionsNCT02059005 · 2014-11-18

PCI and Renal Denervation in Hypertensive Patients With Acute Coronary SyndromesNCT02272920 · 2014-10-01

Alpha-1 Anti-Trypsin (AAT) Treatment in Acute Myocardial InfarctionNCT01936896 · 2013-12-01

Bedside Sleep MedicineNCT01924507 · 2013-08-01

Predictors and Outcomes of In-hospital HFpEF in AMI PatientsNCT03351179 · 2013-01-01

Effects of Microcurrent in a Cardiovascular Rehabilitation Home-based ProgramNCT01887080 · 2012-09-01

IK-5001 for the Prevention of Remodeling of the Ventricle and Congestive Heart Failure After Acute Myocardial InfarctionNCT01226563 · 2012-04-01

"ESTIMATION Study" for Endocardial Mesenchymal Stem Cells Implantation in Patients After Acute Myocardial InfarctionNCT01394432 · 2011-07-01

Effect of the Biomarker Copeptin in Managing Patients With Suspected Acute Coronary Syndrome (ACS)NCT01498731 · 2011-04-01

Post-Myocardial Infarction Remodeling Prevention TherapyNCT01213251 · 2010-12-01

Hair Cortisol and Testosterone Levels in Patients With and Without Acute Myocardial Infarction(MI)NCT01144065 · 2010-08-01

Anakinra to Prevent Adverse Post-infarction Remodeling (2)NCT01175018 · 2010-07-01

Prevalence of Sleep Disordered BreathingNCT01011647 · 2009-11-01

Safety and Efficacy on Cell-based Therapy in Patients With Recent Large Acute Myocardial InfarctionNCT00691834 · 2009-08-01

Effects of Telmisartan on Ischemic Cardiovascular Events in High-risk Hypertensive PatientsNCT00863980 · 2009-04-01

HIV Treatment and CVD EventsNCT01054638 · 2009-03-01

Carvedilol Vascular Efficacy TrialNCT01484327 · 2009-01-01

Effects of Pyruvate in Patients With Cardiogenic Shock and Intra-aortic Balloon CounterpulsationNCT00604331 · 2008-08-01

N-3 Fatty Acids for the Prevention of Atrial Fibrillation in Patients With Acute Heart FailureNCT00692718 · 2008-07-01

Effect of Intravenous Immunglobulin (IVIG) After Myocardial InfarctionNCT00430885 · 2007-02-01

β Blocker Use and Mortality in Hospital Survivors of Acute Myocardial Infarction Without Heart FailureNCT02786654 · 2007-01-01

Intensive Insulin Therapy in Non-diabetic Patients With Acute Myocardial Infarction and HyperglycaemiaNCT00362778 · 2006-01-01

Common interventions

PlaceboDRUG3 Admission in the Cardiac Intensive Care Unit (CICU)OTHER1 Alpha 1-AntitrypsinDRUG1 AnakinraDRUG1 autologous bone marrow-derived cellsBIOLOGICAL1 Blood samplingDIAGNOSTIC_TEST1 Blopress (Candesartan)DRUG1 Cardiovascular Risk FactorsOTHER1 CarvedilolDRUG1 Center-Based Cardiac RehabOTHER1 Choice of Hospital or home-based CR + Movn ApplicationOTHER1 Choice of Hospital or home-based CR + Movn Application + NudgeOTHER1 clinical characteristics, previous history, laboratory bio-markers, echocardiographic measurements, angiographic findings,clinical outcomesCOMBINATION_PRODUCT1 Clinical implementation of hs-cTnTDIAGNOSTIC_TEST1 ControlOTHER1 Coronary Angio Computed TomographyDIAGNOSTIC_TEST1 CPAPDEVICE1 CT angiography, FFR-CT and stress CT myocardial perfusionDIAGNOSTIC_TEST1 DapagliflozinDRUG1 Dapagliflozin 10Mg TabDRUG1 Dexcom ONE Continuous Glucose Monitoring SystemDEVICE1 Discharge homeBEHAVIORAL1 Dual Site PacingDEVICE1 EducationBEHAVIORAL1 Empagliflozin 10 mgDRUG1

Leading sponsors

University College, London3 Charite University, Berlin, Germany2 Elpen Pharmaceutical Co. Inc.2 Hospices Civils de Lyon2 Virginia Commonwealth University2 Abbott RDx Cardiometabolic1 Assistance Publique - Hôpitaux de Paris1 Associação Fundo de Incentivo à Pesquisa1 AstraZeneca1 Bellerophon BCM LLC1 Bispebjerg Hospital1 Cardio Med Medical Center1 Copenhagen University Hospital, Rigshospitalet1 Denver Health and Hospital Authority1 Dr. med. Mahir Karakas1

Trial status mix

COMPLETED39

UNKNOWN18

RECRUITING6

TERMINATED3

NOT_YET_RECRUITING2

WITHDRAWN2

ENROLLING_BY_INVITATION1

Phase mix

NA20

PHASE38

PHASE27

PHASE45

PHASE11

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.